Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
DNA Repair|April 26, 2003
Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndromeIda Casorelli, Judith Offman, Luca Mele, et al.
Cancer Research|September 17, 2005
High mobility group A1 is a molecular target for MYCN in human neuroblastomaGiuseppe Giannini, Fabio Cerignoli, Massimiliano Mellone, et al.
Oncoimmunology|April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ productionCristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
Molecular Carcinogenesis|March 6, 2012
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1Isabella Massimi, Francesca Guerrieri, Marialaura Petroni, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2015
Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitorsLoana Musso, Raffaella Cincinelli, Valentina Zuco, et al.
European Journal of Human Genetics : EJHG|March 18, 2010
The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer casesInes Zanna, Piera Rizzolo, Francesco Sera, et al.
The Journal of Organic Chemistry|May 30, 2018
Synthesis of Bromoundecyl Resorc[4]arenes and Applications of the Cone Stereoisomer as Selector for Liquid ChromatographySilvia Corradi, Giulia Mazzoccanti, Francesca Ghirga, et al.
Frontiers in Immunology|February 21, 2025
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interactionFrancesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
The Journal of Biological Chemistry|January 14, 2005
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splittingAnnamaria Naggi, Benito Casu, Marta Perez, et al.
Molecular Carcinogenesis|November 26, 2003
EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancerGiuseppe Giannini, Maria Irene Ambrosini, Lucia Di Marcotullio, et al.
Pageof 20